Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007205
Filing Date
2021-05-14
Accepted
2021-05-14 12:31:53
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20210331x10q.htm   iXBRL 10-Q 1275902
2 EX-31.1 krbp-20210331xex31d1.htm EX-31.1 22982
3 EX-31.2 krbp-20210331xex31d2.htm EX-31.2 19440
4 EX-32.1 krbp-20210331xex32d1.htm EX-32.1 7612
5 EX-32.2 krbp-20210331xex32d2.htm EX-32.2 7596
  Complete submission text file 0001558370-21-007205.txt   5899100

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20210331.xsd EX-101.SCH 44499
7 EX-101.CAL krbp-20210331_cal.xml EX-101.CAL 31337
8 EX-101.DEF krbp-20210331_def.xml EX-101.DEF 217629
9 EX-101.LAB krbp-20210331_lab.xml EX-101.LAB 416193
10 EX-101.PRE krbp-20210331_pre.xml EX-101.PRE 360951
11 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20210331x10q_htm.xml XML 960862
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 21923135
SIC: 2836 Biological Products, (No Diagnostic Substances)